Aim Immunotech Inc (AIM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 01-2006 | 12-2005 | 01-2005 | 12-2004 | 01-2004 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 3,106 | 3,827 | 840 | 8,813 | 1,276 |
| Marketable Securities | N/A | 12,377 | N/A | 7,924 | N/A |
| Receivables | 4,590 | 96 | 4,607 | 139 | 5,166 |
| Inventories | 5,984 | 1,767 | 5,483 | 2,148 | 5,683 |
| Income taxes - deferred | 1,586 | N/A | 1,236 | N/A | 559 |
| Other current assets | 420 | 0 | 1,942 | 0 | 1,398 |
| TOTAL | $16,132 | $18,209 | $14,306 | $19,290 | $14,272 |
| Non-Current Assets | |||||
| PPE Net | 3,617 | 4,185 | 3,842 | 3,303 | 3,954 |
| Investments And Advances | 0 | 35 | 0 | 35 | 0 |
| Intangibles | 0 | 795 | 0 | 908 | 0 |
| Other Non-Current Assets | 463 | 1,430 | 315 | 1,757 | 165 |
| TOTAL | $4,080 | $6,445 | $4,157 | $6,003 | $4,119 |
| Total Assets | $20,212 | $24,654 | $18,463 | $25,293 | $18,391 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 230 | N/A | 243 | 2,007 | 200 |
| Accounts payable and accrued liabilities | 1,544 | 991 | 1,600 | 526 | 2,910 |
| Accrued Expenses | 1,895 | 865 | 2,404 | 1,012 | 2,343 |
| Other current liabilities | 834 | N/A | 938 | N/A | 779 |
| TOTAL | $4,523 | $1,856 | $5,185 | $3,545 | $7,232 |
| Non-Current Liabilities | |||||
| Long Term Debt | 2,564 | 4,171 | 2,794 | 188 | 2,216 |
| aiOther Non-Current Liabilities | 46 | 0 | 0 | 0 | 0 |
| TOTAL | $2,610 | $4,171 | $2,794 | $188 | $2,216 |
| Total Liabilities | $7,133 | $6,027 | $7,979 | $3,733 | $9,448 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 3,927 | 116 | 3,921 | 94 | 3,921 |
| Common Shares | 1,599 | 56 | 1,595 | 50 | 1,595 |
| Retained earnings | 7,576 | -147,652 | 5,026 | -136,464 | 3,485 |
| Other shareholders' equity | 304 | -171 | 304 | -10 | 304 |
| TOTAL | $13,079 | $18,627 | $10,484 | $21,560 | $8,943 |
| Total Liabilities And Equity | $20,212 | $24,654 | $18,463 | $25,293 | $18,391 |